NASDAQ:MVIS

MicroVision Stock Forecast, Price & News

$12.83
+0.12 (+0.94 %)
(As of 09/17/2021 04:00 PM ET)
Add
Compare
Today's Range
$12.47
$12.86
50-Day Range
$12.22
$15.90
52-Week Range
$1.52
$28.00
Volume4.82 million shs
Average Volume16.18 million shs
Market Capitalization$2.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.93
30 days | 90 days | 365 days | Advanced Chart
Receive MVIS News and Ratings via Email

Sign-up to receive the latest news and ratings for MicroVision and its competitors with MarketBeat's FREE daily newsletter.


MicroVision logo

About MicroVision

MicroVision, Inc. engages in the development of laser beam scanning technology. It offers its product under the PicoP brand. PicoP scanning technology has addressing the following market segments Interactive and non-interactive projected displays, 3D Perceptive LiDAR sensing for consumer electronics, Augmented/Mixed Reality (AR/MR) and 3D Perceptive LiDAR sensing for automotive active collision avoidance. The company was founded in May 1993 and is headquartered in Redmond, WA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

0.88 out of 5 stars

Computer And Technology Sector

811th out of 858 stocks

Electronic Components, Not Elsewhere Classified Industry

10th out of 11 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











MicroVision (NASDAQ:MVIS) Frequently Asked Questions

Is MicroVision a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MicroVision in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MicroVision stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MVIS, but not buy additional shares or sell existing shares.
View analyst ratings for MicroVision
or view top-rated stocks.

What stocks does MarketBeat like better than MicroVision?

Wall Street analysts have given MicroVision a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MicroVision wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is MicroVision's next earnings date?

MicroVision is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for MicroVision
.

How were MicroVision's earnings last quarter?

MicroVision, Inc. (NASDAQ:MVIS) issued its quarterly earnings data on Wednesday, August, 4th. The electronics maker reported ($0.04) earnings per share for the quarter, meeting the Zacks' consensus estimate of ($0.04). The electronics maker had revenue of $0.75 million for the quarter, compared to analysts' expectations of $0.90 million. MicroVision had a negative trailing twelve-month return on equity of 39.05% and a negative net margin of 1,221.29%.
View MicroVision's earnings history
.

How has MicroVision's stock price been impacted by COVID-19?

MicroVision's stock was trading at $0.2348 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MVIS stock has increased by 5,364.2% and is now trading at $12.83.
View which stocks have been most impacted by COVID-19
.

Who are MicroVision's key executives?

MicroVision's management team includes the following people:
  • Sumit Sharma, Chief Executive Officer & Director
  • Stephen P. Holt, Chief Financial Officer
  • Drew G. Markham, Secretary, General Counsel & VP
  • Thomas Luce, Vice President-Business Development
  • Lindsey Stibbard, Paralegal

What is Perry Mulligan's approval rating as MicroVision's CEO?

4 employees have rated MicroVision CEO Perry Mulligan on Glassdoor.com. Perry Mulligan has an approval rating of 74% among MicroVision's employees.

Who are some of MicroVision's key competitors?

What other stocks do shareholders of MicroVision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MicroVision investors own include OrganiGram (OGI), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Sorrento Therapeutics (SRNE), CBL & Associates Properties (CBL), Heat Biologics (HTBX) and Remark (MARK).

What is MicroVision's stock symbol?

MicroVision trades on the NASDAQ under the ticker symbol "MVIS."

Who are MicroVision's major shareholders?

MicroVision's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.54%), Vanguard Group Inc. (5.67%), State Street Corp (2.32%), Geode Capital Management LLC (1.74%), Citadel Advisors LLC (0.00%) and Susquehanna International Group LLP (0.00%). Company insiders that own MicroVision stock include Brian V Turner and Perry Mulligan.
View institutional ownership trends for MicroVision
.

Which major investors are selling MicroVision stock?

MVIS stock was sold by a variety of institutional investors in the last quarter, including Rafferty Asset Management LLC, Mitsubishi UFJ Kokusai Asset Management Co. Ltd., Invesco Ltd., Citigroup Inc., Susquehanna International Group LLP, Millennium Management LLC, Squarepoint Ops LLC, and Cubist Systematic Strategies LLC.
View insider buying and selling activity for MicroVision
or view top insider-selling stocks.

Which major investors are buying MicroVision stock?

MVIS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., State Street Corp, Geode Capital Management LLC, Northern Trust Corp, Coatue Management LLC, Boothbay Fund Management LLC, and Citadel Advisors LLC. Company insiders that have bought MicroVision stock in the last two years include Brian V Turner, and Perry Mulligan.
View insider buying and selling activity for MicroVision
or or view top insider-buying stocks.

How do I buy shares of MicroVision?

Shares of MVIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MicroVision's stock price today?

One share of MVIS stock can currently be purchased for approximately $12.83.

How much money does MicroVision make?

MicroVision has a market capitalization of $2.10 billion and generates $3.09 million in revenue each year. The electronics maker earns $-13,630,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does MicroVision have?

MicroVision employs 52 workers across the globe.

When was MicroVision founded?

MicroVision was founded in 1993.

What is MicroVision's official website?

The official website for MicroVision is www.microvision.com.

Where are MicroVision's headquarters?

MicroVision is headquartered at 6244 185TH AVE NE SUITE 100, REDMOND WA, 98052.

How can I contact MicroVision?

MicroVision's mailing address is 6244 185TH AVE NE SUITE 100, REDMOND WA, 98052. The electronics maker can be reached via phone at (425) 936-6847 or via email at [email protected].


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.